Albert David Limited (BOM:524075)
715.65
-12.35 (-1.70%)
At close: May 26, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 4.12 billion as of May 27, 2026. Its market cap has decreased by -10.72% in one year.
Market Cap
4.12B
Enterprise Value
1.84B
Revenue
3.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
715.65
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.12B, an increase of 5,018.79%. That is a compound annual growth rate of 17.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 4.12B | -2.47% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 6.47B |
| ZIM Laboratories | 5.36B |
| Jenburkt Pharmaceuticals | 5.17B |
| Amanta Healthcare | 4.54B |
| Medico Remedies | 4.07B |
| Medicamen Biotech | 3.44B |
| Gennex Laboratories | 3.08B |
| Trident Lifeline | 3.02B |